It's not the altitude, it's the attitude.
ABOUT US
Scott Fischer (Everest)
OUR STORY
Release Tx was launched in 2023 – but our roots run deeper, going back to the foundation of some of the first preclinical & clinical studies of allogeneic encapsulated cell therapy. Our team has played a central role in the evolution of this technology from a promising idea to a potential life-transforming reality.
OUR VISION
Today, we carry forward our history of innovative science to imagine new possibilities to treat genetic disorders without gene therapy.
We are harnessing our patented encapsulated-cell platform technology distinguished by its unique CNS-directed functionality and versatile multi-application capabilities to improve the lives of patients with limited treatment alternatives and their families.
Leadership Team
OUR
Dr Thomas Mehrling - CEO
Dr Thomas Mehrling - CEO
Team
OUR
Salina Arope, PhD
Salina Arope, PhD
Partners
OUR
Read More >
Françoise Piguet, PhD
Read More >
Françoise Piguet, PhD
Board of Directors
OUR
Ksenija Pavletic
Ksenija Pavletic
Ksenija Pavletic
Ksenija Pavletic
Scientific Advisors
OUR
Read More >
Mikael Pittet, PhD
Read More >
Mikael Pittet, PhD